This conference has been Co-sponsored by Biocytogen and Hai Men Science and Technology Park. We will invite over 20 top experts active at home and abroad in the field of cancer immunology research and industry. They will give a special speech on the topic of “Tumor Immunity” and “Advances in Basic Research of Tumor Immunity, Drug Development, Animal Model Construction and In Vivo Efficacy Evaluation, Tumor Immunization Drug Clinical Trial” to discuss the latest progress and future development trend of tumor immunity. Dr. Chunlin Chen, CEO of Medicilon, has been invited to participant this conference to give a speech at 14:10 on April 22. We are looking forward to your participation.
Dr. Chunlin Chen, CEO of Medicilon
For more information, please click: